Hugh Arnold
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- PI3K/AKT/mTOR signaling in cancer
- Signaling Pathways in Disease
- Protein Kinase Regulation and GTPase Signaling
Papers in
-
- Protease and Inhibitor Mechanisms 4
- Co-authors
- Rosalie C. SearsPeter S. NelsonMichael BonhamCamari FergusonNigel CleggJames T. WhiteBiaoyang LinLeroy Hood
- Journals
- The EMBO Journal (3 papers)Proceedings of the National Academy of Sciences (2 papers)Cancer and Metastasis Reviews (1 paper)The Prostate (1 paper)Cell (1 paper)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Hugh Arnold
18 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 797
- Molecular Biology 2.0k
- Cancer Research 398
- Cell Biology 278
- Pulmonary and Respiratory Medicine 412
Countries citing papers authored by Hugh Arnold
This map shows the geographic impact of Hugh Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh Arnold more than expected).
Fields of papers citing papers by Hugh Arnold
This network shows the impact of papers produced by Hugh Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh Arnold. The network helps show where Hugh Arnold may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hugh Arnold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 44 | |
| 2 | 2014 | 3 | |
| 3 | 2013 | 50 | |
| 4 | 2011 | 65 | |
| 5 | 2010 | 6 | |
| 6 | 2009 | 94 | |
| 7 | 2009 | 1 | |
| 8 | 2008 | 91 | |
| 9 | 2008 | 177 | |
| 10 | CIP2A Inhibits PP2A in Human Malignancies Hit paper breakdown → | 2007 | 533 |
| 11 | 2007 | 160 | |
| 12 | 2007 | 70 | |
| 13 | 2006 | 213 | |
| 14 | A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells Hit paper breakdown → | 2004 | 619 |
| 15 | 2003 | 60 | |
| 16 | 2002 | 32 | |
| 17 | 2002 | 368 | |
| 18 | Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma. | 2002 | 73 |
About Hugh Arnold
Hugh Arnold is a scholar working on Immunology and Allergy, Cancer Research, Oncology, Molecular Biology and Immunology, having authored 18 papers that have together received 2.7k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (5 papers), Protease and Inhibitor Mechanisms (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Prostate Cancer Treatment and Research (3 papers), Toxin Mechanisms and Immunotoxins (3 papers), Cancer Mechanisms and Therapy (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Oncology (797 citations), Molecular Biology (2.0k citations), Cancer Research (398 citations), Cell Biology (278 citations) and Pulmonary and Respiratory Medicine (412 citations). Hugh Arnold has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Rosalie C. Sears, Peter S. Nelson, Michael Bonham, Camari Ferguson, Nigel Clegg, James T. White, Biaoyang Lin, Leroy Hood, P. Todd Stukenberg and Shirish Shenolikar. Their work appears in journals such as The EMBO Journal, Proceedings of the National Academy of Sciences, Cancer and Metastasis Reviews, The Prostate and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.